Literature DB >> 22309204

Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides.

Jessica Kneidl1, Bettina Löffler, Michele C Erat, Julia Kalinka, Georg Peters, Johannes Roth, Katarzyna Barczyk.   

Abstract

CD163 is a multi-ligand scavenger receptor exclusively expressed by monocytes and macrophages, which is released after their activation during sepsis (sCD163). The biological relevance of sCD163, however, is not yet clear. We now demonstrate that sCD163 exhibits direct antimicrobial effects by recognizing a specific subfragment ((6) F1(1) F2(2) F2(7) F1) of fibronectin (FN) bound to staphylococcal surface molecules. Moreover, contact with staphylococci promotes sCD163-shedding from monocyte surface via induction of metalloproteinases ADAM10 and ADAM17. sCD163 subsequently binds to Staphylococcus aureus via FN peptides and strongly amplifies phagocytosis as well as killing by monocytes and to a lesser extend by neutrophils. This mechanism exhibits additional paracrine effects because staphylococci additionally opsonized by sCD163 induce higher activation and more efficient killing activity of non-professional phagocytes like endothelial cells. Targeting pathogen-bound FN by sCD163 would be a very sophisticated strategy to attack S. aureus as any attempt of the pathogen to avoid this defence mechanism will automatically bring about loss of adherence to the host protein FN, which is a pivotal patho-mechanism of highly invasive staphylococcal strains. Thus, we report a novel function for sCD163 that is of particular importance for immune defence of the host against S. aureus infections.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309204     DOI: 10.1111/j.1462-5822.2012.01766.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  27 in total

1.  Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure.

Authors:  Hong Ye; Li-Yuan Wang; Jing Zhao; Kai Wang
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

2.  VentX expression in tumor-associated macrophages promotes phagocytosis and immunity against pancreatic cancers.

Authors:  Yi Le; Hong Gao; William Richards; Lei Zhao; Ronald Bleday; Thomas Clancy; Zhenglun Zhu
Journal:  JCI Insight       Date:  2020-07-23

3.  Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions.

Authors:  Perla Abigail Alvarado-Vazquez; Laura Bernal; Candler A Paige; Rachel L Grosick; Carolina Moracho Vilrriales; David Wilson Ferreira; Cristina Ulecia-Morón; E Alfonso Romero-Sandoval
Journal:  Immunobiology       Date:  2017-05-16       Impact factor: 3.144

4.  The macrophage soluble receptor AIM/Api6/CD5L displays a broad pathogen recognition spectrum and is involved in early response to microbial aggression.

Authors:  Vanesa G Martinez; Cristina Escoda-Ferran; Inês Tadeu Simões; Satoko Arai; Marc Orta Mascaró; Esther Carreras; Mario Martínez-Florensa; José Yelamos; Toru Miyazaki; Francisco Lozano
Journal:  Cell Mol Immunol       Date:  2014-03-03       Impact factor: 11.530

Review 5.  CD163 and inflammation: biological, diagnostic, and therapeutic aspects.

Authors:  Anders Etzerodt; Søren K Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

Review 6.  Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology.

Authors:  Xiaofei Yu; Chunqing Guo; Paul B Fisher; John R Subjeck; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2015-06-17       Impact factor: 6.242

7.  Equine Arteritis Virus Uses Equine CXCL16 as an Entry Receptor.

Authors:  Sanjay Sarkar; Lakshman Chelvarajan; Yun Young Go; Frank Cook; Sergey Artiushin; Shankar Mondal; Kelsi Anderson; John Eberth; Peter J Timoney; Theodore S Kalbfleisch; Ernest Bailey; Udeni B R Balasuriya
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

8.  Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities.

Authors:  Michelle L D'Antoni; Mary Margaret Byron; Phillip Chan; Napapon Sailasuta; Carlo Sacdalan; Pasiri Sithinamsuwan; Somporn Tipsuk; Suteeraporn Pinyakorn; Eugene Kroon; Bonnie M Slike; Shelly J Krebs; Vedbar S Khadka; Thep Chalermchai; Kalpana J Kallianpur; Merlin Robb; Serena Spudich; Victor Valcour; Jintanat Ananworanich; Lishomwa C Ndhlovu
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

9.  Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages.

Authors:  Anders Etzerodt; Mie Rostved Rasmussen; Pia Svendsen; Athena Chalaris; Jeanette Schwarz; Ian Galea; Holger Jon Møller; Søren Kragh Moestrup
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

Review 10.  The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging.

Authors:  Jens Haugbølle Thomsen; Anders Etzerodt; Pia Svendsen; Søren K Moestrup
Journal:  Oxid Med Cell Longev       Date:  2013-05-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.